Back
Supernus Pharmaceuticals Stock Price Chart
Sponsored
SUPN
Sponsored
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
37
SUPN
Supernus Pharmaceuticals
Last Price:
30.09
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.
Supernus Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.93 | Buy |
20-day SMA: | 30.73 | Sell |
50-day SMA: | 31.48 | Sell |
200-day SMA: | 29.08 | Buy |
8-day EMA: | 30.07 | Buy |
20-day EMA: | 30.61 | Sell |
50-day EMA: | 30.8 | Sell |
200-day EMA: | 30.22 | Sell |
Supernus Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 45.28 | Sell |
Chaikin Money Flow: | -179304 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.55 - 32.99) | Sell |
Bollinger Bands (100): | (27.4 - 32.04) | Buy |
Supernus Pharmaceuticals Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 30.09 while SUPN 8-day simple moving average is 29.93, which is a Buy signal.
- The stock price of SUPN is 30.09 while Supernus Pharmaceuticals 20-day SMA is 30.73, which makes it a Sell.
- Supernus Pharmaceuticals 50-day simple moving average is 31.48 while SUPN share price is 30.09, making it a Sell technically.
- SUPN stock price is 30.09 and Supernus Pharmaceuticals 200-day simple moving average is 29.08, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
37
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $30.09. The Score for SUPN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.65B
Price in USD:
30.09
Share Volume:
218.43K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
38.09
52-Week Low:
21.99
Sell
37
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 30.09 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 30.09 while SUPN 8-day exponential moving average is 30.07, which is a Buy signal.
- The stock price of SUPN is 30.09 while Supernus Pharmaceuticals 20-day EMA is 30.61, which makes it a Sell.
- Supernus Pharmaceuticals 50-day exponential moving average is 30.80 while SUPN share price is 30.09, making it a Sell technically.
- SUPN stock price is 30.09 and Supernus Pharmaceuticals 200-day simple moving average is 30.22, creating a Sell signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.35 per share, and an increase next year of $0.31 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting Supernus Pharmaceuticals is a Sell
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 45.28, which suggest Supernus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Supernus Pharmaceuticals is (29.55 - 32.99), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is (27.4 - 32.04), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.